GetTopicDetailResponse(id=8a11e9628eb, topicName=羅米地辛, introduction=羅米地辛, content=null, image=null, comments=3, allHits=1452, url=https://h5.medsci.cn/topic?id=79628, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=46482, tagList=[TagDto(tagId=46482, tagName=羅米地辛)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2213780, encodeId=12572213e8070, content=<a href='/topic/show?id=8a11e9628eb' target=_blank style='color:#2F92EE;'>#羅米地辛#</a> <a href='/topic/show?id=ce4111636139' target=_blank style='color:#2F92EE;'>#Ro-CHOP#</a> <a href='/topic/show?id=58231163623d' target=_blank style='color:#2F92EE;'>#TFH淋巴瘤#</a>, objectTitle=Ro-CHOP對比CHOP在初治外周T細(xì)胞淋巴瘤患者中的療效：Ro-CHOP試驗(yàn)的最終分析, objectType=article, longId=828530, objectId=c7788285302f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240707/1720364064354_5579292.jpg, objectUrl=/article/show_article.do?id=c7788285302f, replyNumber=0, likeNumber=96, createdTime=2024-07-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c7788285302f, moduleTitle=Ro-CHOP對比CHOP在初治外周T細(xì)胞淋巴瘤患者中的療效：Ro-CHOP試驗(yàn)的最終分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c7788285302f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196508, encodeId=d40d2196508eb, content=<a href='/topic/show?id=305e1482998' target=_blank style='color:#2F92EE;'>#PTCL#</a> <a href='/topic/show?id=8a11e9628eb' target=_blank style='color:#2F92EE;'>#羅米地辛#</a> <a href='/topic/show?id=94fb1129e52c' target=_blank style='color:#2F92EE;'>#CHOP治療#</a>, objectTitle=【JCO】屢敗屢戰(zhàn)：羅米地辛+CHOP治療初治PTCL的III期研究陰性結(jié)果及評述, objectType=article, longId=818483, objectId=e68b8184832f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing.jpg, objectUrl=/article/show_article.do?id=e68b8184832f, replyNumber=0, likeNumber=89, createdTime=2024-04-01, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=e68b8184832f, moduleTitle=【JCO】屢敗屢戰(zhàn)：羅米地辛+CHOP治療初治PTCL的III期研究陰性結(jié)果及評述, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e68b8184832f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1987853, encodeId=d69b198e853dc, content=<a href='/topic/show?id=8a11e9628eb' target=_blank style='color:#2F92EE;'>#羅米地辛#</a>, objectTitle=J Clin Oncol：CHOP方案加用羅米地辛治療復(fù)發(fā)/難治性外周T細(xì)胞淋巴瘤的療效和安全性, objectType=article, longId=221472, objectId=77c32214e24c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77c32214e24c, replyNumber=0, likeNumber=131, createdTime=2022-03-04, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77c32214e24c, moduleTitle=J Clin Oncol：CHOP方案加用羅米地辛治療復(fù)發(fā)/難治性外周T細(xì)胞淋巴瘤的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=77c32214e24c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987852, encodeId=ada1198e85233, content=<a href='/topic/show?id=8a11e9628eb' target=_blank style='color:#2F92EE;'>#羅米地辛#</a>, objectTitle=Stem Cells Int：羅米地辛通過抑制組蛋白脫乙酰酶活性促進(jìn)人類間充質(zhì)干細(xì)胞的成骨和成脂分化, objectType=article, longId=138622, objectId=4180138622b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4180138622b0, replyNumber=0, likeNumber=94, createdTime=2018-06-13, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4180138622b0, moduleTitle=Stem Cells Int：羅米地辛通過抑制組蛋白脫乙酰酶活性促進(jìn)人類間充質(zhì)干細(xì)胞的成骨和成脂分化, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4180138622b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987851, encodeId=6045198e8511f, content=<a href='/topic/show?id=8a11e9628eb' target=_blank style='color:#2F92EE;'>#羅米地辛#</a>, objectTitle=Blood：羅米地辛與普拉曲沙的聯(lián)合治療難治性/復(fù)發(fā)性T細(xì)胞淋巴瘤可獲得高反應(yīng)率。, objectType=article, longId=120438, objectId=26471204387a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26471204387a, replyNumber=0, likeNumber=80, createdTime=2017-11-19, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26471204387a, moduleTitle=Blood：羅米地辛與普拉曲沙的聯(lián)合治療難治性/復(fù)發(fā)性T細(xì)胞淋巴瘤可獲得高反應(yīng)率。, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=26471204387a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
